Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Perindopril with calcium channel blocker
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Perindopril erbumine 8mg / Amlodipine 5mg tablets
0205051ACAAADAD
|
Perindopril erbumine with amlodipine | Perindopril with calcium channel blocker | Cardiovascular System | 22 |
|
Perindopril erbumine 4mg / Amlodipine 5mg tablets
0205051ACAAAAAA
|
Perindopril erbumine with amlodipine | Perindopril with calcium channel blocker | Cardiovascular System | 20 |
|
Perindopril erbumine 4mg / Amlodipine 10mg tablets
0205051ACAAABAB
|
Perindopril erbumine with amlodipine | Perindopril with calcium channel blocker | Cardiovascular System | 15 |
|
Perindopril erbumine 8mg / Amlodipine 10mg tablets
0205051ACAAACAC
|
Perindopril erbumine with amlodipine | Perindopril with calcium channel blocker | Cardiovascular System | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.